Adaptive Biotechnologies
ADPT
ADPT
295 hedge funds and large institutions have $2.11B invested in Adaptive Biotechnologies in 2026 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 101 increasing their positions, 95 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.12% more ownership
Funds ownership: 98.49% → 98.62% (+0.12%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
14% less capital invested
Capital invested by funds: $2.44B → $2.11B (-$334M)
Holders
295
Holding in Top 10
2
Calls
$1.14M
Puts
$165K
Top Buyers
| 1 | +$42.8M | |
| 2 | +$27M | |
| 3 | +$21.9M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$21.4M |
| 5 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
+$20.6M |
Top Sellers
| 1 | -$44.9M | |
| 2 | -$30.6M | |
| 3 | -$20.3M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$19M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$16.1M |
